ClinicalTrials.gg
CompletedNCT07799545Updated Sep 2, 2026

Reducing Turkey High Cesarean Section Rates

An interventional study of Antenatal education in Birth, First, Birth Outcome, Adverse and Breast Feeding, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Dec 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 27 studies in Pregnancy Complications with a site in Turkey — 2 open to participants now, 4 under way, none of them phase 3. Pregnancy Complications · Turkey.

Enrollment
6th of 19
120 · median 85
Started
2025
with 1 other
No phase
18 of 27
1 open now
Registered
26th of 27
by date

Among the 27 studies in Pregnancy Complications with a site in Turkey, this one is the 6th largest by enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2025, is one of 18 with no phase, and was the 26th registered.

Pregnancy Complications

411 studies on the registry are indexed under Pregnancy Complications; 113 are open to participants now.

Browse Pregnancy Complications studies →

Open to participants now

2 of the 27 studies in Pregnancy Complications with a site in Turkey are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 92 Pregnancy Complications studies recruiting now, 44 (48%) set no upper age limit and 45 (49%) stop at 75 or younger; 22 take children under 18; 35 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Pregnancy Complications with a site in Turkey, or all of them as a file.
02

Study summary

Considering the increasing rates of cesarean delivery in Turkey, we aimed to research the impact of antenatal education on pregnancy, the childbirth process, the cesarean section rate, and the postpartum period through a randomized controlled study. METHOD: A total of 120 pregnant women (40 in the education group and 80 in the control group) with a gestational age of 28 weeks or more were included in the study from the Üsküdar. The education group trained face to face in the Childbirth Preparation Class. Only if, pre- and post-training tests were administered to the education group to evaluate sociodemographic characteristics, educational needs, birth preferences, satisfaction with the training, and the behavioral outcomes gained from the training.

Read the detailed description

In this context, given the increase in cesarean section rates, we designed a study incorporating both quantitative and qualitative data to investigate the effect of educating pregnant women about childbirth, the labor process, and the postpartum period. We aimed to examine the relationship between participants' receipt of antenatal education and mode of delivery (vaginal birth/cesarean section), the institution where the birth took place, age, and the number of informational phone calls received. In addition, among volunteers who participated in the pregnancy education program, we aimed to evaluate their educational needs, birth preferences, satisfaction with the training, and the impact of the training on their.

03

Conditions studied

  • Birth, First
  • Birth Outcome, Adverse
  • Breast Feeding

Keywords

  • Antenatal education
  • Cesarean section
  • Normal delivery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Years over 18.
  • Pregnancy over 28 weeks (primiparous).
  • To live in Üsküdar.
  • No additional diseases that may affect maternal and neonatal outcomes.

Exclusion criteria

Exclusion Criteria:

  • Patients with high-risk pregnancies.
  • Patients with maternal comorbidities (gestational hypertension, preeclampsia, uncontrolled diabetes or gestational diabetes, , vascular diseases, degenerative joint and connective tissue diseases, mental illness).
  • Women with known chronic disease.
  • Have a history of cesareans.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Antenatal education

    40 pregnant women who were selected according to the inclusion and exclusion criteria and who had completed Childbirth Preparation Class formed the intervention group. Then, the pregnant women who registered in our system have been given numbers. They have been sequentially numbered using a method that employs a central computer mechanism to implement the random assignment sequence. From these numbers, 80 people were selected using a single-blind random sampling method. Records of selected pregnant women were enrolled in the control group, with an allocation ratio of 1:2. In addition, a semi-structured questionnaire was administered to the intervention group before and after the training. The pre- and post-training questionnaire results of the pregnant women in this group were analyzed to investigate the effects of the training on birth preference, fear of childbirth, behavioral sociodemographic data, satisfaction rate with the training, fear of childbirth and breastfeeding-infantcare

    Other: Antenatal education

  • No intervention
    Control group

    The age, number of telephone consultations/information sessions, preferred hospital type (public/private), and final delivery method (normal/cesarean) of the participants in both groups were recorded.

Interventions

  • OtherAntenatal education

    Pregnancy Information Class Pregnancy information training is conducted by a family medicine specialist and a midwife using the Ministry of Health's current guidelines and presentations provided as training material, with theoretical instruction and one-on-one question-and-answer sessions. The training lasts a total of 4 hours in two sessions per day.

06

What researchers measure

Primary outcomes

  1. Comparison of the mode of delivery and the institution where the birth hospital

    Data Collection: The age, number of telephone consultations/information sessions, preferred hospital type (public/private), and final delivery method (normal/cesarean) of the participants in both groups were recorded. In addition, socio-demographic data (age, education, income, occupation, spouse's age, etc.), birth preferences (normal/vaginal or cesarean), 10 questions (1-5 scale) asking why they preferred normal delivery, 8 questions (1-5 scale) asking why they preferred cesarean delivery, and factors influencing their birth preference were recorded before the training. After the training, qualitative and quantitative data, including open-ended questions on the training needs and satisfaction of the study group, were recorded.

    Time frame: through study completion, an average of 6 months.

07

Study locations

1 site
  • Sağlık bilimleri üniversitesi
    Istanbul, Turkey (Türkiye)
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Dec 2025, 0 months.

Of 119 non-industry interventional studies with no phase under Pregnancy Complications, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's 0 months is below that.

Counting every sponsor, half of 119 studies reached it within 26 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2026
First posted
Sep 2, 2026
StartActual
Dec 1, 2025
Primary completionActual
Dec 5, 2025
CompletionActual
May 1, 2026
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07799545
Responsible party
Sponsor
First posted
Sep 2, 2026
Start date
Dec 1, 2025
Primary completion
Dec 5, 2025
Completion
May 1, 2026
Last update
Sep 2, 2026

Study contacts

Emrullah ŞANLAN, 2
study director · Saglik Bilimleri Universitesi

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion